|
2025
|
P/S
|
Manuals; newsletters; pamphlets and brochures; pharmaceutical information leaflets; quick referen... |
|
|
P/S
|
Providing online information regarding patient experiences with plaque psoriasis treatments, name... |
|
2024
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the aut... |
|
|
P/S
|
emergency contraceptive tablets |
|
|
P/S
|
Pharmaceutical and medicinal preparations and substances |
|
|
P/S
|
Information, education, advisory and consultancy services in the field of ophthalmology and optom... |
|
|
P/S
|
Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of ... |
|
|
Invention
|
Long acting glp-1/gip dual agonists.
The present invention relates to long acting glucagon-like ... |
|
|
Invention
|
Glp-1/gip dual agonists.
The present invention relates to long acting glucagon-like peptide-1 an... |
|
|
Invention
|
Perfusion system.
A perfusion container for directly administering to patients a dose of an anti... |
|
|
P/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations for the prevention of breast cancer in post-menopausal women; Pharmac... |
|
|
Invention
|
Topical formulations and uses thereof.
Provided herein include formulations for topical administ... |
|
|
Invention
|
Glp-1/gip dual, glp-1/gcg dual and glp-1/gip/gcg triple receptor agonists. The present invention ... |
|
|
Invention
|
Glp-1/gip dual, glp-1/gcg dual and glp-1/gip/gcg triple receptor agonists. The present disclosure... |
|
|
Invention
|
Glp-1 analog for use in the treatment of metabolic disorders. The disclosure relates to methods o... |
|
|
Invention
|
Stable cyclosporine ophthalmic formulation and manufacturing process thereof. The present inventi... |
|
|
Invention
|
Methods and compositions for treating plaque psoriasis. This disclosure relates to methods of tre... |
|
|
Invention
|
Methods and compositions for treating plaque psoriasis.
This disclosure relates to methods of tr... |
|
|
Invention
|
Novel glp-1 analogues.
The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1)(... |
|
|
Invention
|
Once daily isotretinoin composition. The present invention relates to a method of treating acne c... |
|
|
P/S
|
Retail pharmacy services; mail order pharmacy services; pharmaceutical services, namely, processi... |
|
|
P/S
|
Medicinal and pharmaceutical preparations. |
|
|
Invention
|
Topical cyclosporine-containing formulations and uses thereof.
Provided herein are formulations ... |
|
|
Invention
|
Stable pharmaceutical composition of histamine h2‐receptor antagonist. The present disclosure rel... |
|
|
Invention
|
Stable protein compositions of anti-pd1 antibody. The invention relates to stable compositions of... |
|
|
Invention
|
Intravenous infusion dosage form for pemetrexed.
The present invention relates to an intravenous... |
|
2023
|
Invention
|
Stable pharmaceutical composition of an amine drug. The present disclosure relates to a stable mu... |
|
|
Invention
|
Glp-1 analogues.
The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37)... |
|
|
Invention
|
Infusion dosage form of norepinephrine. The present invention provides a ready to use stable aque... |
|
|
P/S
|
Eye drops; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of dermatological conditions |
|
|
P/S
|
Cardiovascular drugs for use for the prevention of stroke;
cardiovascular drugs for use in the t... |
|
|
Invention
|
Multi-particulate pharmaceutical composition of quetiapine.
The present invention discloses an e... |
|
|
P/S
|
Emergency contraceptive kit composed of oral contraceptives, pregnancy test kits for home use and... |
|
|
Invention
|
Parenteral unit dosage form of dihydroergotamine.
A parenteral unit dosage form comprising an aq... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurologic disorders, disorders of the nervous s... |
|
|
Invention
|
Extended release liquid compositions of guaifenesin.
The present invention relates to extended r... |
|
|
Invention
|
Methods for treatment of subjects with plaque psoriasis of the scalp.
The disclosure relates to ... |
|
|
Invention
|
Methods for treatment of subjects with plaque psoriasis of the scalp. The disclosure relates to a... |
|
|
Invention
|
Combination therapy comprising an anti-il-23 antibody and a corticosteroid for treating psoriasis... |
|
2022
|
Invention
|
Method of injecting octreotide acetate into the body.
A method of providing and/or injecting oct... |
|
|
Invention
|
Process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof.
The pres... |
|
|
Invention
|
Process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof. The prese... |
|
|
Invention
|
Perfusion system. A perfusion container for directly administering to patients a dose of an antin... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of vertigo; Medicinal preparations a... |
|
|
P/S
|
Medical device for treating and diagnosing dermatological conditions |
|
|
Invention
|
Method of injecting dihydroergotamine into the body.
A method is provided for the acute treatmen... |
|
|
Invention
|
Method of injecting dihydroergotamine into the body. A method is provided for the acute treatment... |
|
|
Invention
|
Extended release multiparticulates of ranolazine. The present invention relates to an extended re... |
|
|
P/S
|
Intestinal disorder medicine for the treatment of ulcerative colitis; pharmaceutical preparations... |
|
|
P/S
|
Ophthalmic drops; ophthalmological preparations; pharmaceutical preparations for ocular or intrao... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular disease |
|
|
P/S
|
Ophthalmic drops; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular ... |
|
|
P/S
|
Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the trea... |
|
|
P/S
|
ophthalmic preparations; ophthalmic drops, namely, eye drops; pharmaceutical products for ophthal... |
|
|
P/S
|
pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, auto... |
|
|
Invention
|
Topical cyclosporine-containing formulations and uses thereof. Provided herein are formulations f... |
|
|
Invention
|
Perfusion dosage form. The present invention relates to a method for enabling hospitals or clinic... |
|
|
Invention
|
Stable cyclosporine ophthalmic formulation and manufacturing process thereof.
A stable nanomicel... |
|
|
Invention
|
Stable cyclosporine ophthalmic formulation and manufacturing process thereof. A stable nanomicell... |
|
|
Invention
|
Glp-1 analogues. The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) ... |
|
|
Invention
|
Cyclosporine formulations for use in patients undergoing cataract surgery.
A method of preparing... |
|
|
Invention
|
Cyclosporine formulations for use in patients undergoing cataract surgery. A method of preparing ... |
|
|
Invention
|
Non-steroidal anti-inflammatory ophthalmic compositions. The disclosure provides compositions and... |
|
|
Invention
|
Dexamethasone for treatment of blepharitis.
The present invention relates to a method of treatin... |
|
|
Invention
|
Dexamethasone for treatment of blepharitis. The present invention relates to a method of treating... |
|
2021
|
Invention
|
Glp-1/gip dual agonists.
The present disclosure provides methods and systems for hyperparameter ... |
|
|
Invention
|
Parenteral dosage form of diltiazem.
A parenteral dosage form of diltiazem, comprising a ready-t... |
|
2020
|
Invention
|
Methods for treatment of subjects with psoriatic arthritis.
This disclosure relates to an anti-I... |
|
2019
|
Invention
|
Parenteral dosage form of carboplatin.
A parenteral dosage form having an infusion container fil... |
